•Imaging manifestations of malignancy in inflammatory bowel disease: patterns, pitfalls and pearls
•FUT2 non-secretor status is not associated with disease phenotype or outcomes in patients with Crohn's disease
•GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease
•The Roles of Four Neutrophil-Derived Proteins as Non-Invasive Biomarkers in the Assessment of Inflammatory Bowel Disease
•The Roles of Complementary Structured Exercise and Physical Therapy in The Aging and Older Adult IBD Patient Care Team